Victorian healthcare leaders ensured that our work was impactful, ethical and sustainable.

Board of Directors

The Board of Directors comprised leaders of the 10 member organisations of the Melbourne Genomics Health Alliance, an Independent Director, and an Independent Chair.

The Board provided oversight of the Alliance’s program of work, establishing appropriate strategies, objectives and policies.

The Board was chaired by Catherine Walter AM, a lawyer and company director. A representative from the Victorian Department of Jobs, Skills, Industry and Regions was appointed as an Observer.

Meet our Board members

Committees of the Board

Finance, Audit and Risk Committee

This committee assisted the Board in fulfilling its statutory, fiduciary and regulatory responsibilities in respect of oversight, risk management and corporate governance. It also assisted in fostering a strategic approach to financial management and a risk aware culture.

It was chaired by Lucy Franzmann, Chief Financial Officer at the University of Melbourne from June 2024.

Advisory bodies

Community Advisory Group

Champions of consumer rights in healthcare, the members of this group advised on community engagement for each of our projects: when it was needed, how to approach it, and whose voices must be heard.

The Community Advisory Group completed its work in November 2024.

Meet the group and its Chair, Kellie-Ann Jolly.

Melbourne Genomics acknowledges the Wurundjeri people of the Kulin Nation, on whose lands we work, and all First Nations peoples across Victoria. We pay respect to Elders past and present. We also acknowledge the First Nations health professionals, researchers and leaders who are shaping the future of genomic medicine.

© 2014–2026 Melbourne Genomics Health Alliance